Abstract:Study objective-The aim was to assess the relationship between survival, tumour stage, and the interval from first symptom to diagnosis (SDI, or duration of symptoms).Design-This was a retrospective follow up study ofa cohort ofpatients registered in the tumour registry of the Hospital del Mar (Barcelona).Setting-Hospital based tumour registry, with patients derived mainly from the City of Barcelona.Participants-1247 cases of lung, breast, stomach, colon, or rectal cancer were analysed using survival curves an… Show more
“…9 A greater delay in diagnosis could be associated with greater mortality in urinary tract, colon and breast cancers, 33,44,45 though other studies have shown no such association for breast, colorectal, lung and gastroesophageal cancers. 26,[44][45][46][47] Still other studies found elevated mortality with short diagnostic intervals for lung cancer 48,49 or high mortality with short and long diagnostic intervals for colorectal cancer (i.e., a salud pública de méxico / vol. 58…”
Section: Time Between Receipt Of Mammography Results and Diagnostic Bmentioning
confidence: 99%
“…Variables that had a p<0.20 in the bivariate analysis and those considered by the literature were taken into account in the multiple analysis. 7,9,12,[24][25][26][27][28][29] The life 40.7% in stage III, and 7.4% in stage IV. The median health care times estimated in the study were the following: total time = 139 natural days (IQR=82.5-258), time from when a woman felt a symptom to when she consulted about a doctor about it = 30 natural days (IQR=6-150), time from the receipt of the suspicious mammography results to diagnostic biopsy = 31 natural days (IQR=14-56) and time from diagnostic biopsy to initiation of treatment = 37 natural days (IQR=18-63).…”
Efecto de la demora en la atención sobre la supervivencia de mujeres mexicanas con cáncer de mama. Salud Publica Mex 2016;58:237-250.
ResumenObjetivo. Estimar el efecto del tiempo de atención sobre la supervivencia de mujeres con cáncer de mama. Material y métodos. Se realizó el análisis retrospectivo de 854 mujeres atendidas en 11 hospitales entre 2007 y 2009. Se emplearon estimadores de Kaplan-Meier y un modelo de riesgos proporcionales de Cox. Resultados. 10.5% se diagnosticó en etapa I, mientras que 82.1% demoró más de 67 días entre la percepción de un síntoma y el inicio del tratamiento. La mediana del tiempo desde la entrega de los resultados de la mastografía hasta la biopsia fue de 31 días (RIQ 14-56); en comparación con quienes se encontraron en el cuartil 1 (Q1), la supervivencia fue menor en aquellas que se encontraron en los Q3 y Q4 (HR=1.68, IC95% 0.94-3.00; HR=1.76, IC95% 1.04-2.98, respectivamente). Conclusiones. Se sugiere reducir el tiempo desde la entrega de los resultados de la mastografía a la biopsia diagnóstica para incrementar la supervivencia.Palabras clave: cáncer de mama; demora en la atención; supervivencia; México The median time from receipt of results of the mammography to biopsy was 31 days (IQR 14-56). Compared with those who were in quartile I (Q1), survival was lower among those in Q3 and Q4 (HR=1.68, 95%CI 0.94-3.00; HR=1.76, 95% CI 1.04-2.98, respectively). Conclusions. To increase survival, it is suggested that the time between receipt of the mammography results and diagnostic biopsy be reduced.
“…9 A greater delay in diagnosis could be associated with greater mortality in urinary tract, colon and breast cancers, 33,44,45 though other studies have shown no such association for breast, colorectal, lung and gastroesophageal cancers. 26,[44][45][46][47] Still other studies found elevated mortality with short diagnostic intervals for lung cancer 48,49 or high mortality with short and long diagnostic intervals for colorectal cancer (i.e., a salud pública de méxico / vol. 58…”
Section: Time Between Receipt Of Mammography Results and Diagnostic Bmentioning
confidence: 99%
“…Variables that had a p<0.20 in the bivariate analysis and those considered by the literature were taken into account in the multiple analysis. 7,9,12,[24][25][26][27][28][29] The life 40.7% in stage III, and 7.4% in stage IV. The median health care times estimated in the study were the following: total time = 139 natural days (IQR=82.5-258), time from when a woman felt a symptom to when she consulted about a doctor about it = 30 natural days (IQR=6-150), time from the receipt of the suspicious mammography results to diagnostic biopsy = 31 natural days (IQR=14-56) and time from diagnostic biopsy to initiation of treatment = 37 natural days (IQR=18-63).…”
Efecto de la demora en la atención sobre la supervivencia de mujeres mexicanas con cáncer de mama. Salud Publica Mex 2016;58:237-250.
ResumenObjetivo. Estimar el efecto del tiempo de atención sobre la supervivencia de mujeres con cáncer de mama. Material y métodos. Se realizó el análisis retrospectivo de 854 mujeres atendidas en 11 hospitales entre 2007 y 2009. Se emplearon estimadores de Kaplan-Meier y un modelo de riesgos proporcionales de Cox. Resultados. 10.5% se diagnosticó en etapa I, mientras que 82.1% demoró más de 67 días entre la percepción de un síntoma y el inicio del tratamiento. La mediana del tiempo desde la entrega de los resultados de la mastografía hasta la biopsia fue de 31 días (RIQ 14-56); en comparación con quienes se encontraron en el cuartil 1 (Q1), la supervivencia fue menor en aquellas que se encontraron en los Q3 y Q4 (HR=1.68, IC95% 0.94-3.00; HR=1.76, IC95% 1.04-2.98, respectivamente). Conclusiones. Se sugiere reducir el tiempo desde la entrega de los resultados de la mastografía a la biopsia diagnóstica para incrementar la supervivencia.Palabras clave: cáncer de mama; demora en la atención; supervivencia; México The median time from receipt of results of the mammography to biopsy was 31 days (IQR 14-56). Compared with those who were in quartile I (Q1), survival was lower among those in Q3 and Q4 (HR=1.68, 95%CI 0.94-3.00; HR=1.76, 95% CI 1.04-2.98, respectively). Conclusions. To increase survival, it is suggested that the time between receipt of the mammography results and diagnostic biopsy be reduced.
“…In another study 6 out of 29 patients became clinically incurable while waiting (9). The other studies did not nd any association between advanced stage:survival and delay (6,7,11).…”
“…There is a need for a screening programme to pick up breast cancers early as it has been shown that early diagnosis leads to better survival especially in breast cancer. 5,13,14 Along with this there should be decentralization in the government health infrastructure enabling easy access to surgeons and pathologists so that delay caused by reference to higher centre can be avoided.…”
Background: Around the world breast cancer is the most common cancer in women. In India, peak incidence is between 45-50 years of age. Early diagnosis improves survival, hence reducing diagnostic delay in breast cancer will have major social and economic implications besides improving the quality of life. This observational study aims to decipher various factors influencing diagnostic delay so that early treatment can be instituted.Methods: We interviewed 212 consecutive patients who attended the twice weekly breast clinic conducted by Department of general surgery and department of radiotherapy, government medical college, Kozhikode between September 2014 and February 2015. All patients with primary breast cancer were included in the study. Exclusion criteria included recurrence, second primaries, history of partial treatment and incomplete records. Finally, we interviewed 202 patients with the help of a pretested semi-structured questionnaire.Results: In present study, the commonest age group was 40-50 years with 62.4% participants presenting with early breast cancer and 37.6% having advanced breast cancer. Most of present study subjects were educated up to high school and unemployed. Awareness about breast cancer was 74.25% but many were ignorant of its symptomatology. Practice of breast self-examination (BSE) was low at 32.1%. Side and quadrant were statistically significant factor.Conclusions: In present study religion, educational status, marital status, breast cancer awareness, practice of BSE and location of tumor were statistically significant factors influencing delay in diagnosis. There was a general lack of knowledge about the importance of self-examination in breast cancer which needs health education and need for active social propaganda in print and electronic media regarding its importance. In future institution of a screening programme will hasten diagnosis and improve survival of breast cancer patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.